Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …

Summary COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …

Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary
infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality. The …

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …

Background We evaluated the incidence of invasive pulmonary aspergillosis among
intubated patients with critical COVID-19 and evaluated different case definitions of invasive …

Abstract Background Coronavirus disease 2019 (COVID-19)–associated pulmonary
aspergillosis (CAPA) occurs in critically ill patients with COVID-19. Risks and outcomes …

Background Superinfections, including invasive pulmonary aspergillosis (IPA), are well-
known complications of critically ill patients with severe viral pneumonia. Aim of this study …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Dear Editor, Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis
(CAPA) has emerged as an important complication among patients with acute respiratory …